Showing results (71-80 of 149) with videos related to
Sort By:
Pageof 15
American Journal of Ophthalmology|February 25, 2024
Association of Ocular Manifestations of Marfan Syndrome With Cardiovascular ComplicationsElaine M Tran, Karen M Wai, Andrea L Kossler, et al.JAMA Ophthalmology|August 7, 2025
Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative VitreoretinopathyAmer F Alsoudi, Asad Loya, Karen Wai, et al.JAMA Ophthalmology|October 26, 2023
Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery OcclusionKaren M Wai, Austen Knapp, Cassie A Ludwig, et al.BMC Ophthalmology|May 31, 2024
Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practiceAndrew A Moshfeghi, Rahul N Khurana, Hadi Moini, et al.Retina (Philadelphia, Pa.)|February 18, 2026
The Risk of Retinal Breaks or Detachment in Fellow Eye with Lattice Degeneration after Primary Rhegmatogenous Retinal DetachmentLeo Arnal, Yeabsira Mesfin, Anish Salvi, et al.Survey of Ophthalmology|March 15, 2016
Acute macular neuroretinopathy: A comprehensive review of the literatureKavita V Bhavsar, Sally Lin, Ehsan Rahimy, et al.Retina (Philadelphia, Pa.)|August 9, 2014
Diabetic tractional retinal detachment repair by vitreoretinal fellows in a county health systemEhsan Rahimy, John D Pitcher, Christopher J Gee, et al.Journal of Vitreoretinal Diseases|March 5, 2026
Prevalence of Systemic Comorbidities and Ocular Complications in Patients With Bilateral Retinal TelangiectasiaCindy S Zhao, Diana V Do, Steven R Sanislo, et al.Retina (Philadelphia, Pa.)|August 30, 2018
LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITISNadim Rayess, Anthony Obeid, Philip P Storey, et al.Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 9, 2025
Short-term effects of tetracycline use in patients with diabetic retinopathyAhmed M Alshaikhsalama, Amer F Alsoudi, Karen M Wai, et al.Pageof 15